Insensitivity versus poor response to tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective cohort study.
Sae OchiKazuyoshi SaitoFumitaka MizoguchiShigeaki KatoYoshiya TanakaPublished in: Arthritis research & therapy (2020)
In future research, poor and insensitivity to bDMARDs should be assessed separately to fully elucidate the aetiology of, and risk factors for, bDMARD refractoriness.